Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Z Culig, J Hoffmann, M Erdel et al. · British Journal of Cancer · 1999
Abstract only
11 papersQuestions on this topic
Z Culig, J Hoffmann, M Erdel et al. · British Journal of Cancer · 1999
Abstract only
O van Tellingen, M T Huizing, V R Nannan Panday et al. · British Journal of Cancer · 1999
Abstract only
P A Lazo · British Journal of Cancer · 1999 · Review
Abstract only
E Mitry, E Baudin, M Ducreux et al. · British Journal of Cancer · 1999
Abstract only
Kathleen T. Brady, Susan C. Sonne · PubMed · 1999 · Review
Full textCC0
T Sheard, P Maguire · British Journal of Cancer · 1999 · Meta-analysis
Abstract only
J Kurebayashi, T Otsuki, C K Tang et al. · British Journal of Cancer · 1999 · Case report
Abstract only
J S Waters, A Norman, D Cunningham et al. · British Journal of Cancer · 1999 · Randomised trial
Abstract only
Bridget F. Grant · PubMed · 1998 · Review
Full textCC0
Chester G. Moore, Carl J. Mitchell · Emerging Infectious Diseases · 1997 · Review
Abstract only
Henri Begleiter, Theodore Reich, VICTOR M. HESSELBROCK et al. · PubMed · 1995
Full textCC0